Author name: Sreenivasulu Malkari

Blog

L&T, Dr Reddy’s Labs, Coal India, Varun Beverages — Check Price Target Changes From Analysts

L&T, Dr Reddy’s Labs, Coal India, Varun Beverages — Check Price Target Changes From Analysts Larsen & Toubro Ltd., Dr Reddy’s Laboratories Ltd., Coal India Ltd., Varun Beverages Ltd. are among the companies that have drawn commentary from top brokerages on Thursday. Analysts have tweaked share price targets after these companies announced their September quarter

Blog

Ixigo Targets Double-Digit Growth After Disruptions Weigh In Q2

Ixigo Targets Double-Digit Growth After Disruptions Weigh In Q2 Travel tech platform Ixigo on Wednesday reported a consolidated loss of Rs 3.46 crore for the September quarter. Despite this, Aloke Bajpai, the chief executive officer of Ixigo, attributes the slip in this quarter to a one-off, non-recurring ESOP or Employee Stock Option Plan settlement this

Blog

US-China Trade Tensions Ease: A Net Positive For Indian Equities

US-China Trade Tensions Ease: A Net Positive For Indian Equities The recent de-escalation of US-China trade tensions following the meeting between Presidents Trump and Xi should harbour a ‘net positive’ environment for Indian equities, according to Manpreet Gill, Chief Investment Officer for Africa, Middle East, and Europe at Standard Chartered. Speaking to NDTV Profit, Gill

Blog

Five Star Business Finance Q2 Results: Motilal Oswal Maintains ‘Buy’ Rating Despite Soft Quarter

Five Star Business Finance Q2 Results: A Mixed Bag for Investors Five Star Business Finance Ltd. recently reported its Q2 FY26 results, which were marked by a soft operating performance. Despite this, brokerage firm Motilal Oswal has maintained its ‘buy’ rating on the stock, citing improved growth visibility. Q2 FY26 Results: A Snapshot The company’s

Scroll to Top